Spots Global Cancer Trial Database for lenalidomide 20 mg
Every month we try and update this database with for lenalidomide 20 mg cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013) | NCT01953692 | Myelodysplastic... Multiple Myelom... Hodgkin Lymphom... Non-Hodgkin Lym... Diffuse Large B... Follicular Lymp... Primary Mediast... | Pembrolizumab Lenalidomide 20... Lenalidomide 25... | 18 Years - | Merck Sharp & Dohme LLC | |
Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell Lymphoma | NCT04113226 | Chemotherapy Diffuse Large B... Elderly | Rituximab Lenalidomide 20... Comprehensive G... Activities of d... | 75 Years - | Centre Hospitalier Universitaire, Amiens |